Huge hepatocellular carcinoma greater than 10 cm in diameter worsens prognosis by causing distant recurrence after curative resection
Author:
Affiliation:
1. Department of Gastroenterological Surgery I; Hokkaido University Graduate School of Medicine; Sapporo Hokkaido Japan
Publisher
Wiley
Subject
Oncology,General Medicine,Surgery
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/jso.24501/fullpdf
Reference35 articles.
1. Hepatocellular carcinoma;Forner;Lancet,2012
2. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis;Mazzaferro;N Engl J Med,1996
3. A combination therapy with transarterial chemo-lipiodolization and systemic chemo-infusion for large extensive hepatocellular carcinoma invading portal vein in comparison with conservative management;Jang;Cancer Chemother Pharmacol,2007
4. Ablation of hepatocellular carcinoma;Kim;Best Pract Res Clin Gastroenterol,2014
5. SHARP Investigators Study Group. Sorafenib in advanced hepatocellular carcinoma;Llovet;N Engl J Med,2008
Cited by 53 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The impacts of physical factors on huge hepatocellular carcinoma treated by transarterial chemoembolization combined with radiotherapy;Future Oncology;2024-09-12
2. A nomogram model for early recurrence of HBV-related hepatocellular carcinomas after radical hepatectomy;Frontiers in Endocrinology;2024-09-02
3. Improved survival outcome of curative liver resection for Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma in the era of tyrosine kinase inhibitors;Hepatology Research;2024-07-26
4. Efficacy and Safety of Transarterial Chemoembolization and Hepatic Arterial Infusion Chemotherapy Combined with Lenvatinib in Treating Massive Hepatocellular Carcinoma;2024-07-24
5. Neoadjuvant therapy of sequential TACE, camrelizumab, and apatinib for single huge hepatocellular carcinoma (NEO-START): study protocol for a randomized controlled trial;Trials;2024-07-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3